Amryt Pharmaceuticals DAC
AMYTN/A
NASDAQHealthcare🇺🇸North America
Drugs in Pipeline
3
Phase 3 Programs
3
Upcoming Catalysts
2
Next Catalyst
Jul 21, 2026
18wMarket Overview
Stock performance and key metrics
AMYT News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
Oleogel-S10
Epidermolysis Bullosa
metreleptin
Partial Lipodystrophy
Lomitapide
Homozygous Familial Hypercholesterolaemia (HoFH)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Oleogel-S10 | Phase 3 | Epidermolysis Bullosa | - | - |
metreleptin | Phase 3 | Partial Lipodystrophy | - | - |
Lomitapide | Phase 3 | Homozygous Familial Hypercholesterolaemia (HoFH) | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply